Case Report: Exceptional Response to Nivolumab Plus Cabozantinib in a Patient with Extrarenal Clear Cell Renal Cell Carcinoma
FRONTIERS IN ONCOLOGY（2023）
Key words
case report,extrarenal clear cell renal cell carcinoma,splenic renal cell carcinoma,nivolumab,cabozantinib,immunotherapy,targeted therapy,tyrosine kinase
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined